Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 306

1.

Vitamin e-loaded membrane dialyzers reduce hemodialysis inflammaging.

Sepe V, Gregorini M, Rampino T, Esposito P, Coppo R, Galli F, Libetta C.

BMC Nephrol. 2019 Nov 15;20(1):412. doi: 10.1186/s12882-019-1585-6.

PMID:
31729973
2.

Does the renal expression of Toll-like receptors play a role in patients with IgA nephropathy?

Ciferska H, Honsova E, Lodererova A, Hruskova Z, Neprasova M, Vachek J, Suchanek M, Zima T, Coppo R, Tesar V, Novak J, Maixnerova D.

J Nephrol. 2019 Sep 5. doi: 10.1007/s40620-019-00640-z. [Epub ahead of print]

PMID:
31489594
3.

Role of miRNAs in tumor and endothelial cell interactions during tumor progression.

Orso F, Quirico L, Dettori D, Coppo R, Virga F, Ferreira LC, Paoletti C, Baruffaldi D, Penna E, Taverna D.

Semin Cancer Biol. 2019 Aug 3. pii: S1044-579X(19)30169-5. doi: 10.1016/j.semcancer.2019.07.024. [Epub ahead of print] Review.

PMID:
31386907
4.

Pediatric IgA Nephropathy in Europe.

Coppo R.

Kidney Dis (Basel). 2019 Jun;5(3):182-188. doi: 10.1159/000495751. Epub 2019 Jan 24. Review.

5.

Standardized Outcomes in Nephrology-Glomerular Disease (SONG-GD): establishing a core outcome set for trials in patients with glomerular disease.

Carter SA, Lightstone L, Cattran D, Bagga A, Barbour SJ, Barratt J, Boletis J, Caster D, Coppo R, Fervenza FC, Floege J, Hladunewich M, Hogan JJ, Kitching AR, Lafayette R, Malvar A, Radhakrishnan J, Rovin BH, Zhang H, Gutman T, Howell M, Logeman C, Shen JI, Teixeira-Pinto A, Alexander SI, Cho Y, Craig JC, Harris D, Johnson DW, Kerr PG, Ryan J, Viecelli AK, Wang AY, Wilkie M, Scholes-Robertson N, Tong A; SONG-GD Initiative.

Kidney Int. 2019 Jun;95(6):1280-1283. doi: 10.1016/j.kint.2019.01.047. No abstract available.

PMID:
31122702
6.

Evaluating a New International Risk-Prediction Tool in IgA Nephropathy.

Barbour SJ, Coppo R, Zhang H, Liu ZH, Suzuki Y, Matsuzaki K, Katafuchi R, Er L, Espino-Hernandez G, Kim SJ, Reich HN, Feehally J, Cattran DC; International IgA Nephropathy Network.

JAMA Intern Med. 2019 Jul 1;179(7):942-952. doi: 10.1001/jamainternmed.2019.0600. Erratum in: JAMA Intern Med. 2019 Jul 1;179(7):1007.

PMID:
30980653
7.

Erratum.

Bellur SS, Roberts ISD, Troyanov S, Royal V, Coppo R, Cook HT, Cattran D, Arce Terroba Y, Maria Asunis A, Bajema I, Bertoni E, Bruijn JA, Cannata-Ortiz P, Casartelli D, Maria Di Palma A, Ferrario F, Fortunato M, Furci L, Gakiopoulou H, Galesic Ljubanovic D, Giannakakis K, Gomà M, Gröne HJ, Gutiérrez E, Haider SA, Honsova E, Ioachim E, Karkoszka H, Kipgen D, Maldyk J, Mazzucco G, Orhan D, Ozluk Y, Pantzaki A, Perkowska-Ptasinska A, Riispere Z, Soderberg MP, Steenbergen E, Stoppacciaro A, Sundelin Von Feilitzen B, Tardanico R.

Nephrol Dial Transplant. 2019 Mar 16. pii: gfz001. doi: 10.1093/ndt/gfz001. [Epub ahead of print] No abstract available.

PMID:
30879042
8.

Podocytopathy in the mesangial proliferative immunoglobulin A nephropathy: new insights into the mechanisms of damage and progression.

Trimarchi H, Coppo R.

Nephrol Dial Transplant. 2019 Jan 29. doi: 10.1093/ndt/gfy413. [Epub ahead of print]

PMID:
30698804
9.

Reproducibility of the Oxford classification of immunoglobulin A nephropathy, impact of biopsy scoring on treatment allocation and clinical relevance of disagreements: evidence from the VALidation of IGA study cohort.

Bellur SS, Roberts ISD, Troyanov S, Royal V, Coppo R, Cook HT, Cattran D, Arce Terroba Y, Asunis AM, Bajema I, Bertoni E, Bruijn JA, Cannata-Ortiz P, Casartelli D, Maria Di Palma A, Ferrario F, Fortunato M, Furci L, Gakiopoulou H, Galesic Ljubanovic D, Giannakakis K, Gomà M, Gröne HJ, Gutiérrez E, Asma Haider S, Honsova E, Ioachim E, Karkoszka H, Kipgen D, Maldyk J, Mazzucco G, Orhan D, Ozluk Y, Pantzaki A, Perkowska-Ptasinska A, Riispere Z, Soderberg MP, Steenbergen E, Stoppacciaro A, Sundelin Von Feilitzen B, Tardanico R.

Nephrol Dial Transplant. 2019 Oct 1;34(10):1681-1690. doi: 10.1093/ndt/gfy337.

PMID:
30561721
10.

Towards a personalized treatment for IgA nephropathy considering pathology and pathogenesis.

Coppo R.

Nephrol Dial Transplant. 2019 Nov 1;34(11):1832-1838. doi: 10.1093/ndt/gfy338.

PMID:
30476257
11.

Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update.

Coppo R, D'Arrigo G, Tripepi G, Russo ML, Roberts ISD, Bellur S, Cattran D, Cook TH, Feehally J, Tesar V, Maixnerova D, Peruzzi L, Amore A, Lundberg S, Di Palma AM, Gesualdo L, Emma F, Rollino C, Praga M, Biancone L, Pani A, Feriozzi S, Polci R, Barratt J, Del Vecchio L, Locatelli F, Pierucci A, Caliskan Y, Perkowska-Ptasinska A, Durlik M, Moggia E, Ballarin JC, Wetzels JFM, Goumenos D, Papasotiriou M, Galesic K, Toric L, Papagianni A, Stangou M, Benozzi L, Cusinato S, Berg U, Topaloglu R, Maggio M, Ots-Rosenberg M, D'Amico M, Geddes C, Balafa O, Quaglia M, Cravero R, Lino Cirami C, Fellstrom B, Floege J, Egido J, Mallamaci F, Zoccali C.

Nephrol Dial Transplant. 2018 Nov 9. doi: 10.1093/ndt/gfy302. [Epub ahead of print]

PMID:
30418652
12.

The Gut-Renal Connection in IgA Nephropathy.

Coppo R.

Semin Nephrol. 2018 Sep;38(5):504-512. doi: 10.1016/j.semnephrol.2018.05.020. Review.

PMID:
30177022
13.

IgA Nephropathy: A European Perspective in the Corticosteroid Treatment.

Coppo R.

Kidney Dis (Basel). 2018 Jun;4(2):58-64. doi: 10.1159/000487265. Epub 2018 Mar 16. Review.

14.

Defective gene expression of the membrane complement inhibitor CD46 in patients with progressive immunoglobulin A nephropathy.

Coppo R, Peruzzi L, Loiacono E, Bergallo M, Krutova A, Russo ML, Cocchi E, Amore A, Lundberg S, Maixnerova D, Tesar V, Perkowska-Ptasińska A, Durlik M, Goumenos D, Gerolymos M, Galesic K, Toric L, Papagianni A, Stangou M, Mizerska-Wasia Membek M, Gesualdo L, Montemurno E, Benozzi L, Cusinato S, Hryszko T, Klinger M, Kamińska D, Krajewska M; VALIGA Study Group of the ERA-EDTA Immunonephrology Working Group.

Nephrol Dial Transplant. 2019 Apr 1;34(4):587-596. doi: 10.1093/ndt/gfy064.

PMID:
29635535
15.

Treatment of IgA nephropathy: Recent advances and prospects.

Coppo R.

Nephrol Ther. 2018 Apr;14 Suppl 1:S13-S21. doi: 10.1016/j.nephro.2018.02.010. Review.

PMID:
29606258
16.

Standardization of pediatric uroradiological terms: A multidisciplinary European glossary.

Vivier PH, Augdal TA, Avni FE, Bacchetta J, Beetz R, Bjerre AK, Blickman J, Cochat P, Coppo R, Damasio B, Darge K, El-Ghoneimi A, Hoebeke P, Läckgren G, Leclair MD, Lobo ML, Manzoni G, Marks SD, Mattioli G, Mentzel HJ, Mouriquand P, Nevéus T, Ntoulia A, Ording-Muller LS, Oswald J, Papadopoulou F, Porcellini G, Ring E, Rösch W, Teixeira AF, Riccabona M.

J Pediatr Urol. 2017 Dec;13(6):641-650. doi: 10.1016/j.jpurol.2017.05.026. Epub 2017 Jul 13.

PMID:
29174378
17.

Standardization of pediatric uroradiological terms: a multidisciplinary European glossary.

Vivier PH, Augdal TA, Avni FE, Bacchetta J, Beetz R, Bjerre AK, Blickman J, Cochat P, Coppo R, Damasio B, Darge K, El-Ghoneimi A, Hoebeke P, Läckgren G, Leclair MD, Lobo ML, Manzoni G, Marks SD, Mattioli G, Mentzel HJ, Mouriquand P, Nevéus T, Ntoulia A, Ording-Muller LS, Oswald J, Papadopoulou F, Porcellini G, Ring E, Rösch W, Teixeira AF, Riccabona M.

Pediatr Radiol. 2018 Feb;48(2):291-303. doi: 10.1007/s00247-017-4006-7. Epub 2017 Nov 15. Review.

18.

Glomerular disease frequencies by race, sex and region: results from the International Kidney Biopsy Survey.

O'Shaughnessy MM, Hogan SL, Thompson BD, Coppo R, Fogo AB, Jennette JC.

Nephrol Dial Transplant. 2018 Apr 1;33(4):661-669. doi: 10.1093/ndt/gfx189.

19.

Differential diagnosis of thrombotic microangiopathy in nephrology.

Sakari Jokiranta T, Viklicky O, Al Shorafa S, Coppo R, Gasteyger C, Macia M, Pankratenko T, Shenoy M, Soylemezoglu O, Tsimaratos M, Wetzels J, Haller H.

BMC Nephrol. 2017 Oct 28;18(1):324. doi: 10.1186/s12882-017-0727-y.

20.

Persistent Microscopic Hematuria as a Risk Factor for Progression of IgA Nephropathy: New Floodlight on a Nearly Forgotten Biomarker.

Coppo R, Fervenza FC.

J Am Soc Nephrol. 2017 Oct;28(10):2831-2834. doi: 10.1681/ASN.2017060639. Epub 2017 Jul 24. No abstract available.

21.

HERV-K and W expression in peripheral mononuclear cells of children with Henoch-Schönlein purpura and relation with TLRs activation.

Bergallo M, Loiacono E, Galliano I, Montanari P, Peruzzi L, Tovo PA, Coppo R.

Minerva Pediatr. 2017 May 4. doi: 10.23736/S0026-4946.17.04717-X. [Epub ahead of print]

PMID:
28472872
22.

The gut-kidney axis in IgA nephropathy: role of microbiota and diet on genetic predisposition.

Coppo R.

Pediatr Nephrol. 2018 Jan;33(1):53-61. doi: 10.1007/s00467-017-3652-1. Epub 2017 Apr 7.

PMID:
28389744
23.

Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial.

Fellström BC, Barratt J, Cook H, Coppo R, Feehally J, de Fijter JW, Floege J, Hetzel G, Jardine AG, Locatelli F, Maes BD, Mercer A, Ortiz F, Praga M, Sørensen SS, Tesar V, Del Vecchio L; NEFIGAN Trial Investigators.

Lancet. 2017 May 27;389(10084):2117-2127. doi: 10.1016/S0140-6736(17)30550-0. Epub 2017 Mar 28.

PMID:
28363480
24.

Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group.

Trimarchi H, Barratt J, Cattran DC, Cook HT, Coppo R, Haas M, Liu ZH, Roberts IS, Yuzawa Y, Zhang H, Feehally J; IgAN Classification Working Group of the International IgA Nephropathy Network and the Renal Pathology Society; Conference Participants.

Kidney Int. 2017 May;91(5):1014-1021. doi: 10.1016/j.kint.2017.02.003. Epub 2017 Mar 22. Review.

25.

C4d deposits in IgA nephropathy: where does complement activation come from?

Coppo R.

Pediatr Nephrol. 2017 Jul;32(7):1097-1101. doi: 10.1007/s00467-016-3575-2. Epub 2017 Feb 14. No abstract available.

PMID:
28197885
26.

Clinical and histological risk factors for progression of IgA nephropathy: an update in children, young and adult patients.

Coppo R.

J Nephrol. 2017 Jun;30(3):339-346. doi: 10.1007/s40620-016-0360-z. Epub 2016 Nov 4. Review.

PMID:
27815919
27.

Erratum to: Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort.

Coppo R, Lofaro D, Camilla RR, Bellur S, Cattran D, Cook HT, Roberts IS, Peruzzi L, Amore A, Emma F, Fuiano L, Berg U, Topaloglu R, Bilginer Y, Gesualdo L, Polci R, Mizerska-Wasiak M, Caliskan Y, Lundberg S, Cancarini G, Geddes C, Wetzels J, Wiecek A, Durlik M, Cusinato S, Rollino C, Maggio M, Praga M, Smerud HK, Tesar V, Maixnerova D, Barratt J, Papalia T, Bonofiglio R, Mazzucco G, Giannakakis C, Soderberg M, Orhan D, Di Palma AM, Maldyk J, Ozluk Y, Sudelin B, Tardanico R, Kipgen D, Steenbergen E, Karkoszka H, Perkowska-Ptasinska A, Ferrario F, Gutierrez E, Honsova E.

Pediatr Nephrol. 2017 Jan;32(1):193-194. No abstract available.

28.

Corticosteroids in IgA Nephropathy: Lessons from Recent Studies.

Coppo R.

J Am Soc Nephrol. 2017 Jan;28(1):25-33. doi: 10.1681/ASN.2016060647. Epub 2016 Sep 26. Review.

29.

A Multicenter Study of the Predictive Value of Crescents in IgA Nephropathy.

Haas M, Verhave JC, Liu ZH, Alpers CE, Barratt J, Becker JU, Cattran D, Cook HT, Coppo R, Feehally J, Pani A, Perkowska-Ptasinska A, Roberts IS, Soares MF, Trimarchi H, Wang S, Yuzawa Y, Zhang H, Troyanov S, Katafuchi R.

J Am Soc Nephrol. 2017 Feb;28(2):691-701. doi: 10.1681/ASN.2016040433. Epub 2016 Sep 9. Erratum in: J Am Soc Nephrol. 2017 May;28(5):1665.

30.

Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort.

Coppo R, Lofaro D, Camilla RR, Bellur S, Cattran D, Cook HT, Roberts IS, Peruzzi L, Amore A, Emma F, Fuiano L, Berg U, Topaloglu R, Bilginer Y, Gesualdo L, Polci R, Mizerska-Wasiak M, Caliskan Y, Lundberg S, Cancarini G, Geddes C, Wetzels J, Wiecek A, Durlik M, Cusinato S, Rollino C, Maggio M, Praga M, K Smerud H, Tesar V, Maixnerova D, Barratt J, Papalia T, Bonofiglio R, Mazzucco G, Giannakakis C, Soderberg M, Orhan D, Di Palma AM, Maldyk J, Ozluk Y, Sudelin B, Tardanico R, Kipgen D, Steenbergen E, Karkoszka H, Perkowska-Ptasinska A, Ferrario F, Gutierrez E, Honsova E.

Pediatr Nephrol. 2017 Jan;32(1):139-150. Epub 2016 Aug 25. Erratum in: Pediatr Nephrol. 2017 Jan;32(1):193-194.

31.

Toll-like receptors are essential for the control of endogenous retrovirus expression in Idiopathic Nephrotic Syndrome.

Bergallo M, Loiacono E, Gambarino S, Montanari P, Galliano I, Coppo R.

Minerva Urol Nefrol. 2017 Apr;69(2):201-208. doi: 10.23736/S0393-2249.16.02658-8. Epub 2016 Jun 29.

32.

miR-214 and miR-148b Targeting Inhibits Dissemination of Melanoma and Breast Cancer.

Orso F, Quirico L, Virga F, Penna E, Dettori D, Cimino D, Coppo R, Grassi E, Elia AR, Brusa D, Deaglio S, Brizzi MF, Stadler MB, Provero P, Caselle M, Taverna D.

Cancer Res. 2016 Sep 1;76(17):5151-62. doi: 10.1158/0008-5472.CAN-15-1322. Epub 2016 Jun 21.

33.

Biomarkers and targeted new therapies for IgA nephropathy.

Coppo R.

Pediatr Nephrol. 2017 May;32(5):725-731. doi: 10.1007/s00467-016-3390-9. Epub 2016 Jun 20. Review.

PMID:
27324471
34.

Outcome of childhood-onset full-house nephropathy.

Ruggiero B, Vivarelli M, Gianviti A, Pecoraro C, Peruzzi L, Benetti E, Ventura G, Pennesi M, Murer L, Coppo R, Emma F.

Nephrol Dial Transplant. 2017 Jul 1;32(7):1194-1204. doi: 10.1093/ndt/gfw230.

PMID:
27270291
35.

IgA nephropathy and infections.

Rollino C, Vischini G, Coppo R.

J Nephrol. 2016 Aug;29(4):463-8. doi: 10.1007/s40620-016-0265-x. Epub 2016 Jan 22. Review.

PMID:
26800970
36.

The MEST score provides earlier risk prediction in lgA nephropathy.

Barbour SJ, Espino-Hernandez G, Reich HN, Coppo R, Roberts IS, Feehally J, Herzenberg AM, Cattran DC; Oxford Derivation, North American Validation and VALIGA Consortia; Oxford Derivation North American Validation and VALIGA Consortia.

Kidney Int. 2016 Jan;89(1):167-75. doi: 10.1038/ki.2015.322.

PMID:
26759049
37.

Liver transplantation for aHUS: still needed in the eculizumab era?

Coppo R, Bonaudo R, Peruzzi RL, Amore A, Brunati A, Romagnoli R, Salizzoni M, Galbusera M, Gotti E, Daina E, Noris M, Remuzzi G.

Pediatr Nephrol. 2016 May;31(5):759-68. doi: 10.1007/s00467-015-3278-0. Epub 2015 Nov 24.

38.

Tonsillectomy in a European Cohort of 1,147 Patients with IgA Nephropathy.

Feehally J, Coppo R, Troyanov S, Bellur SS, Cattran D, Cook T, Roberts IS, Verhave JC, Camilla R, Vergano L, Egido J, Wiecek A, Karkoszka H, Tesar V, Maixnerova D, Ots-Rosenberg M, Quaglia M, Rollino C, Magistroni R, Cusinato S, Cravero R, Peruzzi L, Lundberg S, Gesualdo L, Cancarini G, Feriozzi S, Ferrario F; VALIGA study of ERA-EDTA Immunonephrology Working Group.

Nephron. 2016;132(1):15-24. doi: 10.1159/000441852. Epub 2015 Nov 20.

PMID:
26586175
39.

Ir(III) complexes designed for light-emitting devices: beyond the luminescence color array.

Zanoni KP, Coppo RL, Amaral RC, Murakami Iha NY.

Dalton Trans. 2015 Sep 7;44(33):14559-73. doi: 10.1039/c5dt01644d.

PMID:
26104725
40.

A new monoclonal antibody for detecting degalactosylated IgA1 as serum biomarker of IgA nephropathy.

Coppo R.

Nephrol Dial Transplant. 2015 Aug;30(8):1234-6. doi: 10.1093/ndt/gfv234. Epub 2015 Jun 8. No abstract available.

PMID:
26058592
41.

An international consensus approach to the management of atypical hemolytic uremic syndrome in children.

Loirat C, Fakhouri F, Ariceta G, Besbas N, Bitzan M, Bjerre A, Coppo R, Emma F, Johnson S, Karpman D, Landau D, Langman CB, Lapeyraque AL, Licht C, Nester C, Pecoraro C, Riedl M, van de Kar NC, Van de Walle J, Vivarelli M, Frémeaux-Bacchi V; HUS International.

Pediatr Nephrol. 2016 Jan;31(1):15-39. doi: 10.1007/s00467-015-3076-8. Epub 2015 Apr 11. Review.

PMID:
25859752
42.

The authors reply:.

Troyanov S, Cattran D, Coppo R.

Kidney Int. 2015 Mar;87(3):662-3. doi: 10.1038/ki.2014.402. No abstract available.

43.

Corticosteroids in IgA Nephropathy: A Retrospective Analysis from the VALIGA Study.

Tesar V, Troyanov S, Bellur S, Verhave JC, Cook HT, Feehally J, Roberts IS, Cattran D, Coppo R; VALIGA study of the ERA-EDTA Immunonephrology Working Group.

J Am Soc Nephrol. 2015 Sep;26(9):2248-58. doi: 10.1681/ASN.2014070697. Epub 2015 Feb 12.

44.

Challenges in pediatric renal transplantation.

Peruzzi L, Amore A, Coppo R.

World J Transplant. 2014 Dec 24;4(4):222-8. doi: 10.5500/wjt.v4.i4.222. Review.

45.

The intestine-renal connection in IgA nephropathy.

Coppo R.

Nephrol Dial Transplant. 2015 Mar;30(3):360-6. doi: 10.1093/ndt/gfu343. Epub 2014 Nov 11. Review.

PMID:
25387475
46.

The difficulty in considering modifiable pathology risk factors in children with IgA nephropathy: crescents and timing of renal biopsy.

Coppo R, Davin JC.

Pediatr Nephrol. 2015 Feb;30(2):189-92. doi: 10.1007/s00467-014-2954-9. Epub 2014 Oct 16.

PMID:
25318618
47.

Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens.

Kiryluk K, Li Y, Scolari F, Sanna-Cherchi S, Choi M, Verbitsky M, Fasel D, Lata S, Prakash S, Shapiro S, Fischman C, Snyder HJ, Appel G, Izzi C, Viola BF, Dallera N, Del Vecchio L, Barlassina C, Salvi E, Bertinetto FE, Amoroso A, Savoldi S, Rocchietti M, Amore A, Peruzzi L, Coppo R, Salvadori M, Ravani P, Magistroni R, Ghiggeri GM, Caridi G, Bodria M, Lugani F, Allegri L, Delsante M, Maiorana M, Magnano A, Frasca G, Boer E, Boscutti G, Ponticelli C, Mignani R, Marcantoni C, Di Landro D, Santoro D, Pani A, Polci R, Feriozzi S, Chicca S, Galliani M, Gigante M, Gesualdo L, Zamboli P, Battaglia GG, Garozzo M, Maixnerová D, Tesar V, Eitner F, Rauen T, Floege J, Kovacs T, Nagy J, Mucha K, Pączek L, Zaniew M, Mizerska-Wasiak M, Roszkowska-Blaim M, Pawlaczyk K, Gale D, Barratt J, Thibaudin L, Berthoux F, Canaud G, Boland A, Metzger M, Panzer U, Suzuki H, Goto S, Narita I, Caliskan Y, Xie J, Hou P, Chen N, Zhang H, Wyatt RJ, Novak J, Julian BA, Feehally J, Stengel B, Cusi D, Lifton RP, Gharavi AG.

Nat Genet. 2014 Nov;46(11):1187-96. doi: 10.1038/ng.3118. Epub 2014 Oct 12.

48.

Dramatic effects of eculizumab in a child with diffuse proliferative lupus nephritis resistant to conventional therapy.

Coppo R, Peruzzi L, Amore A, Martino S, Vergano L, Lastauka I, Schieppati A, Noris M, Tovo PA, Remuzzi G.

Pediatr Nephrol. 2015 Jan;30(1):167-72. doi: 10.1007/s00467-014-2944-y. Epub 2014 Aug 31.

PMID:
25173358
49.

Henoch-Schönlein purpura nephritis in children.

Davin JC, Coppo R.

Nat Rev Nephrol. 2014 Oct;10(10):563-73. doi: 10.1038/nrneph.2014.126. Epub 2014 Jul 29. Review.

PMID:
25072122
50.

Dynamics of complement activation in aHUS and how to monitor eculizumab therapy.

Noris M, Galbusera M, Gastoldi S, Macor P, Banterla F, Bresin E, Tripodo C, Bettoni S, Donadelli R, Valoti E, Tedesco F, Amore A, Coppo R, Ruggenenti P, Gotti E, Remuzzi G.

Blood. 2014 Sep 11;124(11):1715-26. doi: 10.1182/blood-2014-02-558296. Epub 2014 Jul 18.

Supplemental Content

Support Center